Berkley W R Corp’s SPAC Exit: A Case Study in Risk Management for VCs

The Berkley W R Corp Playbook: Why Timing

Matters in SPAC Exits

Berkley W R Corp’s full divestment from Aimei Health Technology (AFJK) on June 30, 2026, at $30.30 per share was not just a transaction — it was a risk management masterclass. Within weeks, AFJK’s stock collapsed over 60% to $12.01, proving that Berkley’s exit was prescient. For venture capitalists and private markets investors, this case offers a blueprint for navigating the treacherous waters of SPACs, where speculative fervor often trumps fundamentals.

The lesson is clear: even in a market where SPACs are marketed as shortcuts to public markets, fundamentals still win. Berkley’s disciplined approach — rooted in fundamental value investing — contrasts sharply with the hype-driven narratives that often surround SPACs. For funds and LPs, this case underscores the importance of rigorous due diligence and the willingness to exit when valuations detach from reality.

SPACs: The Allure and the Pitfalls for VCs

SPACs have been a double-edged sword for venture-backed companies and their investors. On one hand, they offer a faster path to liquidity compared to traditional IPOs, which can be critical for founders and early-stage backers. On the other, SPACs are notorious for their structural risks:

• Misaligned incentives: Sponsors often secure outsized equity stakes, creating conflicts of interest that may not align with long-term shareholder value.

• Lack of operational earnings: Many SPACs target pre-revenue or unprofitable companies, relying on growth narratives rather than tangible financials.

• Dilution risks: SPACs frequently impose significant dilution on shareholders through warrants and PIPE investments, eroding value for early investors.

• Market timing traps: SPACs are highly sensitive to market cycles. When sentiment sours, as it did in 2022 and 2023, SPACs become prime candidates for value destruction.

AFJK’s trajectory is a cautionary tale. Despite its promise as a healthcare technology play, the company’s inability to sustain its post-merger valuation reflects the broader challenges of SPACs. Berkley’s exit at $30.30, just before the collapse, highlights the importance of recognizing when a SPAC’s narrative no longer aligns with market realities.

How Berkley’s Strategy Outperformed the SPAC Gamble

Berkley W R Corp’s investment philosophy is rooted in fundamental value investing — a stark contrast to the speculative nature of SPACs. The firm’s decision to exit AFJK entirely was not an emotional reaction but a calculated move based on several key signals:

• Valuation disconnect: AFJK’s post-merger valuation implied aggressive growth assumptions that lacked supporting evidence. Berkley’s analysis likely flagged this as unsustainable.

• Operational red flags: Healthcare technology companies, especially those emerging from SPAC mergers, often face regulatory hurdles, integration challenges, and competitive pressures. Berkley may have anticipated these risks.

• Market sentiment shifts: By mid-2026, SPAC liquidity had dried up, and investor appetite for unproven growth stories had waned. Berkley’s timing aligned with a broader market correction.

The firm’s ability to crystallize gains at $30.30, just before AFJK’s collapse, demonstrates the power of disciplined investing. For VCs, this case serves as a reminder that liquidity events — whether IPOs, SPAC mergers, or secondary sales — should be evaluated through the lens of long-term value, not short-term hype.

What Founders Can Learn from AFJK’s Collapse

For founders raising capital or considering SPAC mergers, AFJK’s story is a stark warning. SPACs are not a panacea for go-to-market challenges or operational gaps. Instead, they often amplify risks:

• Overvaluation risks: Founders may be tempted by high SPAC valuations, but these often come with aggressive performance targets that are difficult to meet.

• Dilution traps: SPAC mergers frequently result in significant dilution, leaving founders and early investors with reduced ownership stakes.

• Regulatory and compliance burdens: SPACs come with stringent disclosure requirements and ongoing compliance costs, which can strain resources.

Founders should approach SPACs with the same rigor they apply to traditional fundraising. Key questions to ask include:

• Does the SPAC sponsor have a track record of value creation, or is this a one-time bet?

• Are the growth projections realistic, or are they based on speculative assumptions?

• What are the terms of the merger, including dilution, warrants, and liquidation preferences?

Berkley’s exit from AFJK underscores the importance of maintaining control over valuation and liquidity events. Founders should prioritize partnerships with investors who share their long-term vision, rather than those who prioritize short-term liquidity.

What LPs Should Demand from Their GPs in a SPAC-Heavy Market

For limited partners (LPs) evaluating venture funds with exposure to SPACs, Berkley’s case offers several takeaways:

• Risk management frameworks: LPs should ask GPs how they assess SPAC investments. Do they rely on fundamental analysis, or are they swayed by market narratives?

• Liquidity planning: SPACs can create unpredictable liquidity events. GPs should demonstrate how they plan to manage exits, especially in volatile markets.

• Diversification strategies: SPACs are inherently risky. LPs should ensure that GPs maintain a balanced portfolio with exposure to both traditional and alternative liquidity paths.

Berkley’s disciplined approach — exiting AFJK before its collapse — should be a benchmark for how GPs manage SPAC risk. LPs should look for funds that prioritize fundamentals over hype, even when it means walking away from attractive but unsustainable opportunities.

The Bottom Line: Fundamentals Trump Narratives

The Berkley W R Corp case is a reminder that in venture capital and private markets, fundamentals still matter. SPACs may offer a faster path to liquidity, but they are not a substitute for rigorous due diligence, operational excellence, or sustainable growth.

For funds, the lesson is clear: prioritize value creation over valuation. For founders, the message is to avoid the SPAC trap unless the terms align with long-term goals. For LPs, the takeaway is to demand transparency and discipline from GPs, especially in markets where speculative narratives can overshadow reality.

As SPAC activity ebbs and flows, Berkley’s AFJK exit stands as a testament to the power of disciplined investing. In a world where hype often trumps substance, it’s a playbook worth emulating.

Source: GuruFocus (2026)